$ASND appeared in 6 mentions from 2 distinct FinTwit voices over the past 12 months, with the first mention on September 22, 2025. Biotech-focused voices dominated discussion of Ascendis Pharma, with @adamfeuerstein accounting for 5 of the 6 mentions. The most recent activity occurred on February 27, 2026, when @adamfeuerstein posted about a trading halt ahead of an FDA decision on Transcon CNP for children with achondroplasia, followed hours later by a post confirming approval of the therapy. @investmentguru_ mentioned $ASND once on January 6, 2026, as part of a broader survey of biotech companies identified as breakout candidates for 2026.